Jintanat Ananworanich

Title: Jintanat Ananworanich: Innovator in HIV Research

Introduction

Jintanat Ananworanich is a prominent inventor based in Rockville, MD, specializing in methods to combat human immunodeficiency virus (HIV) infection. With a total of two patents to his name, he has made significant contributions to the field of immunology and HIV treatment.

Latest Patents

Ananworanich's latest patents focus on innovative methods for inducing an immune response against HIV in subjects undergoing antiretroviral treatment. These methods involve administering an adenovirus vector primer vaccine and a modified vaccinia virus (MVA) vector booster vaccine that encodes mosaic HIV antigens. This approach aims to enhance the immune response in HIV-infected individuals receiving antiretroviral therapy (ART).

Career Highlights

Throughout his career, Ananworanich has worked with notable organizations such as Janssen Vaccines & Prevention B.V. and Beth Israel Deaconess Medical Center, Inc. His work has been instrumental in advancing the understanding and treatment of HIV.

Collaborations

Ananworanich has collaborated with esteemed colleagues, including Frank Tomaka and Maria Grazia Pau, to further his research and innovations in the field of HIV.

Conclusion

Jintanat Ananworanich's contributions to HIV research through his patents and collaborations highlight his commitment to improving treatment options for those affected by the virus. His innovative approaches continue to pave the way for advancements in immunology and patient care.